Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis-Reference-Cited by-同舟云学术

Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis

Published:2022-09-01 Issue:3 Volume:187 Page:438-441
ISSN:1365-2133
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Reich Kristian¹^ORCID,Baraliakos Xenophon²,Coates Laura C.³,Elewski Boni⁴^ORCID,Bao Weibin⁵,Kasparek Torben⁶,Gaillez Corine⁶,Pournara Effie⁶,Aassi Maher⁶,Perella Chiara⁶,Gottlieb Alice B.⁷

Affiliation:

1. Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing University Medical Center Hamburg-Eppendorf Hamburg Germany

2. Rheumazentrum Ruhrgebiet Herne Ruhr-University Bochum Bochum Germany

3. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences University of Oxford Oxford UK

4. Department of Dermatology University of Alabama Birmingham AL USA

5. Novartis Pharmaceuticals Corporation East Hanover NJ USA

6. Novartis Pharma AG Basel Switzerland

7. Department of Dermatology Icahn School of Medicine at Mount Sinai New York NY USA

Abstract

Abstract Secukinumab showed consistent and sustained efficacy in clearing nail psoriasis in patients with psoriatic arthritis, with or without axial manifestations, irrespective of severity of nail involvement. Reduction of nail disease was also associated with response across all musculoskeletal and skin manifestations of psoriatic arthritis.

Funder

Novartis

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.21233

Reference8 articles.

1. The nail as a musculoskeletal appendage--implications for an improved understanding of the link between psoriasis and arthritis;McGonagle;Dermatology,2009

2. Predictors, risk factors, and incidence rates of psoriatic arthritis development in psoriasis patients: a systematic literature review and meta-analysis;Zabotti;Rheumatol Ther,2021

3. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis;Langenbruch;Br J Dermatol,2014

4. Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study;Reich;Br J Dermatol,2021

5. Secukinumab provides sustained improvement in nail psoriasis, signs and symptoms of psoriatic arthritis and low rate of radiographic progression in patients with concomitant nail involvement: 2-year results from the Phase III FUTURE 5 study;Nash;Clin Exp Rheumatol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research hotspots and trends in biological agents for psoriasis: Visualization and bibliometric analysis;Heliyon;2024-06

2. Bayesian network meta-analysis of head-to-head trials for complete resolution of nail psoriasis;Clinical and Experimental Dermatology;2023-04-13